Assembly of Epstein-Barr virus capsid in promyelocytic leukemia nuclear bodies

Journal of Virology

Volumn 89, Issue 17, 2015, Pages 8922-8931

  Wang, Wen Hung ^a   Kuo, Chung Wen ^a   Chang, Li Kwan ^b   Hung, Chen Chia ^a   Chang, Tzu Hsuan ^a   Liu, Shih Tung ^a,c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CAPSID PROTEIN BDLF1; CAPSID PROTEIN BORF1; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; EPSTEIN-BARR VIRAL CAPSID ANTIGEN; NUCLEAR PROTEIN; SMALL INTERFERING RNA; TUMOR PROTEIN; VIRUS ANTIGEN;

ARTICLE; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; CYTOPLASM; EPSTEIN BARR VIRUS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VIRUS PARTICLE; ACTIVE TRANSPORT; BIOSYNTHESIS; CONFOCAL MICROSCOPY; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; PROTEIN TRANSPORT; RNA INTERFERENCE; TUMOR CELL LINE; VIROLOGY; VIRUS CAPSID;

HUMAN HERPESVIRUS 4; MIRIDAE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIGENS, VIRAL; CAPSID; CAPSID PROTEINS; CELL LINE, TUMOR; HEK293 CELLS; HERPESVIRUS 4, HUMAN; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICROSCOPY, CONFOCAL; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN TRANSPORT; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84938935107     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01114-15     Document Type: Article

References (62)

1. Baker TS, Newcomb WW, Booy FP, Brown JC, Steven AC. 1990. Three-dimensional structures of maturable and abortive capsids of equine herpesvirus 1 from cryoelectron microscopy. J Virol 64:563-573.
2. Newcomb WW, Trus BL, Booy FP, Steven AC, Wall JS, Brown JC. 1993. Structure of the herpes simplex virus capsid. Molecular composition of the pentons and the triplexes. J Mol Biol 232:499-511.
3. Trus BL, Newcomb WW, Booy FP, Brown JC, Steven AC. 1992. Distinct monoclonal antibodies separately label the hexons or the pentons of herpes simplex virus capsid. Proc Natl Acad Sci U S A 89:11508-11512. http://dx.doi.org/10.1073/pnas.89.23.11508.
4. Germi R, Effantin G, Grossi L, Ruigrok RW, Morand P, Schoehn G. 2012. Three-dimensional structure of the Epstein-Barr virus capsid. J Gen Virol 93:1769-1773. http://dx.doi.org/10.1099/vir.0.043265-0.
5. Wang WH, Chang LK, Liu ST. 2011. Molecular interactions of Epstein-Barr virus capsid proteins. J Virol 85:1615-1624. http://dx.doi.org/10.1128/JVI.01565-10.
6. Spencer JV, Newcomb WW, Thomsen DR, Homa FL, Brown JC. 1998. Assembly of the herpes simplex virus capsid: preformed triplexes bind to the nascent capsid. J Virol 72:3944-3951.
7. Wingfield PT, Stahl SJ, Thomsen DR, Homa FL, Booy FP, Trus BL, Steven AC. 1997. Hexon-only binding of VP26 reflects differences between the hexon and penton conformations of VP5, the major capsid protein of herpes simplex virus. J Virol 71:8955-8961.
8. Henson BW, Perkins EM, Cothran JE, Desai P. 2009. Self-assembly of Epstein-Barr virus capsids. J Virol 83:3877-3890. http://dx.doi.org/10.1128/JVI.01733-08.
9. Desai P, Akpa JC, Person S. 2003. Residues of VP26 of herpes simplex virus type 1 that are required for its interaction with capsids. J Virol 77: 391-404. http://dx.doi.org/10.1128/JVI.77.1.391-404.2003.
10. Gibson W. 1996. Structure and assembly of the virion. Intervirology 39: 389-400.
11. Mettenleiter TC. 2002. Herpesvirus assembly and egress. J Virol 76:1537-1547. http://dx.doi.org/10.1128/JVI.76.4.1537-1547.2002.
12. Nicholson P, Addison C, Cross AM, Kennard J, Preston VG, Rixon FJ. 1994. Localization of the herpes simplex virus type 1major capsid proteinVP5 to the cell nucleus requires the abundant scaffolding protein VP22a. J Gen Virol 75:1091-1099. http://dx.doi.org/10.1099/0022-1317-75-5-1091.
13. Rixon FJ, Addison C, McGregor A, Macnab SJ, Nicholson P, Preston VG, Tatman JD. 1996. Multiple interactions control the intracellular localization of the herpes simplex virus type 1 capsid proteins. J Gen Virol 77:2251-2260. http://dx.doi.org/10.1099/0022-1317-77-9-2251.
14. Preston VG, Al-Kobaisi MF, McDougall IM, Rixon FJ. 1994. The herpes simplex virus gene UL26 proteinase in the presence of the UL26.5 gene product promotes the formation of scaffold-like structures. J Gen Virol 75:2355-2366. http://dx.doi.org/10.1099/0022-1317-75-9-2355.
15. Homa FL, Brown JC. 1997. Capsid assembly and DNA packaging in herpes simplex virus. Rev Med Virol 7:107-122. http://dx.doi.org/10.1002/(SICI)1099-1654(199707)7:2<107::AID-RMV191>3.0.CO;2-M.
16. Spector DL. 1990. Higher order nuclear organization: three-dimensional distribution of small nuclear ribonucleoprotein particles. Proc Natl Acad Sci U S A 87:147-151. http://dx.doi.org/10.1073/pnas.87.1.147.
17. Everett RD, Chelbi-Alix MK. 2007. PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89:819-830. http://dx.doi.org/10.1016/j.biochi.2007.01.004.
18. Salomoni P, Ferguson BJ, Wyllie AH, Rich T. 2008. New insights into the role of PML in tumour suppression. Cell Res 18:622-640. http://dx.doi.org/10.1038/cr.2008.58.
19. Hodges M, Tissot C, Howe K, Grimwade D, Freemont PS. 1998. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am J Hum Genet 63:297-304. http://dx.doi.org/10.1086/301991.
20. Lallemand-Breitenbach V, de The H. 2010. PML nuclear bodies. Cold Spring Harb Perspect Biol 2:a000661. http://dx.doi.org/10.1101/cshperspect.a000661.
21. Stuurman N, de Graaf A, Floore A, Josso A, Humbel B, de Jong L, van Driel R. 1992. A monoclonal antibody recognizing nuclear matrixassociated nuclear bodies. J Cell Sci 101:773-784.
22. Reineke EL, Kao HY. 2009. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies. Int J Biol Sci 5:366-376.
23. Van Damme E, Laukens K, Dang TH, Van Ostade X. 2010. A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int J Biol Sci 6:51-67.
24. Takahashi Y, Lallemand-Breitenbach V, Zhu J, de The H. 2004. PML nuclear bodies and apoptosis. Oncogene 23:2819-2824. http://dx.doi.org/10.1038/sj.onc.1207533.
25. Guo L, Giasson BI, Glavis-Bloom A, Brewer MD, Shorter J, Gitler AD, Yang X. 2014. A cellular system that degrades misfolded proteins and protects against neurodegeneration. Mol Cell 55:15-30. http://dx.doi.org/10.1016/j.molcel.2014.04.030.
26. Nisole S, Maroui MA, Mascle XH, Aubry M, Chelbi-Alix MK. 2013. Differential roles of PML isoforms. Front Oncol 3:125. http://dx.doi.org/10.3389/fonc.2013.00125.
27. Korioth F, Maul GG, Plachter B, Stamminger T, Frey J. 1996. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res 229:155-158. http://dx.doi.org/10.1006/excr.1996.0353.
28. Ahn JH, Hayward GS. 2000. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 274:39-55. http://dx.doi.org/10.1006/viro.2000.0448.
29. Boutell C, Orr A, Everett RD. 2003. PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0. J Virol 77:8686-8694. http://dx.doi.org/10.1128/JVI.77.16.8686-8694.2003.
30. Adamson AL, Kenney S. 2001. Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol 75:2388-2399. http://dx.doi.org/10.1128/JVI.75.5.2388-2399.2001.
31. Bailey D, O'Hare P. 2002. Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease. J Gen Virol 83:2951-2964.
32. Scherer M, Klingl S, Sevvana M, Otto V, Schilling EM, Stump JD, Muller R, Reuter N, Sticht H, Muller YA, Stamminger T. 2014. Crystal structure of cytomegalovirus IE1 protein reveals targeting of TRIM family memberPMLvia coiled-coil interactions. PLoS Pathog 10:e1004512. http://dx.doi.org/10.1371/journal.ppat.1004512.
33. Cuchet-Lourenco D, Vanni E, Glass M, Orr A, Everett RD. 2012. Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation. J Virol 86:11209-11222. http://dx.doi.org/10.1128/JVI.01145-12.
34. Sides MD, Block GJ, Shan B, Esteves KC, Lin Z, Flemington EK, Lasky JA. 2011. Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells. Virology 416:86-97. http://dx.doi.org/10.1016/j.virol.2011.04.005.
35. Bell P, Lieberman PM, Maul GG. 2000. Lytic but not latent replication of Epstein-Barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol 74:11800-11810. http://dx.doi.org/10.1128/JVI.74.24.11800-11810.2000.
36. Everett RD. 2001. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20:7266-7273. http://dx.doi.org/10.1038/sj.onc.1204759.
37. Salsman J, Zimmerman N, Chen T, Domagala M, Frappier L. 2008. Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS Pathog 4:e1000100. http://dx.doi.org/10.1371/journal.ppat.1000100.
38. Zhong S, Muller S, Ronchetti S, Freemont PS, Dejean A, Pandolfi PP. 2000. Role of SUMO-1-modified PML in nuclear body formation. Blood 95:2748-2752.
39. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss JF, III, Maul GG. 1999. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147:221-234. http://dx.doi.org/10.1083/jcb.147.2.221.
40. Muller S, Matunis MJ, Dejean A. 1998. Conjugation with the ubiquitinrelated modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 17:61-70. http://dx.doi.org/10.1093/emboj/17.1.61.
41. Sides MD, Block GJ, Chadwick RW, Shan B, Flemington EK, Lasky JA. 2011. Epstein-Barr virus latent membrane protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies. Virol J 8:461. http://dx.doi.org/10.1186/1743-422X-8-461.
42. Bentz GL, Whitehurst CB, Pagano JS. 2011. Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9. J Virol 85:10144-10153. http://dx.doi.org/10.1128/JVI.05035-11.
43. Reichelt M, Wang L, Sommer M, Perrino J, Nour AM, Sen N, Baiker A, Zerboni L, Arvin AM. 2011. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus. PLoS Pathog 7:e1001266. http://dx.doi.org/10.1371/journal.ppat.1001266.
44. Glass M, Everett RD. 2013. Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection. J Virol 87:2174-2185. http://dx.doi.org/10.1128/JVI.02950-12.
45. Lu Y, Everett RD. 2015. Analysis of the functional interchange between the IE1 and pp71 proteins of human cytomegalovirus and ICP0 of herpes simplex virus 1. J Virol 89:3062-3075. http://dx.doi.org/10.1128/JVI.03480-14.
46. Doucas V, Ishov AM, Romo A, Juguilon H, Weitzman MD, Evans RM, Maul GG. 1996. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev 10:196-207. http://dx.doi.org/10.1101/gad.10.2.196.
47. Jul-Larsen A, Visted T, Karlsen BO, Rinaldo CH, Bjerkvig R, Lonning PE, Boe SO. 2004. PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication. Exp Cell Res 298:58-73. http://dx.doi.org/10.1016/j.yexcr.2004.03.045.
48. Shishido-Hara Y, Ichinose S, Higuchi K, Hara Y, Yasui K. 2004. Major and minor capsid proteins of human polyomavirus JC cooperatively accumulate to nuclease domain 10 for assembly into virions. J Virol 78: 9890-9903. http://dx.doi.org/10.1128/JVI.78.18.9890-9903.2004.
49. Erickson KD, Bouchet-Marquis C, Heiser K, Szomolanyi-Tsuda E, Mishra R, Lamothe B, Hoenger A, Garcea RL. 2012. Virion assembly factories in the nucleus of polyomavirus-infected cells. PLoS Pathog 8:e1002630. http://dx.doi.org/10.1371/journal.ppat.1002630.
50. Amon W, White RE, Farrell PJ. 2006. Epstein-Barr virus origin of lytic replication mediates association of replicating episomes with promyelocytic leukaemia protein nuclear bodies and replication compartments. J Gen Virol 87:1133-1137. http://dx.doi.org/10.1099/vir.0.81589-0.
51. Chou AH, Chen YL, Hu SH, Chang YM, Wang HL. 2014. Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation. Brain Res 1583:220-229. http://dx.doi.org/10.1016/j.brainres.2014.08.019.
52. Yang YC, Yoshikai Y, Hsu SW, Saitoh H, Chang LK. 2013. Role of RNF4 in the ubiquitination of Rta of Epstein-Barr virus. J Biol Chem 288:12866-12879. http://dx.doi.org/10.1074/jbc.M112.413393.
53. Asai R, Kato A, Kato K, Kanamori-Koyama M, Sugimoto K, Sairenji T, Nishiyama Y, Kawaguchi Y. 2006. Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1. J Virol 80:5125-5134. http://dx.doi.org/10.1128/JVI.02674-05.
54. Chang LK, Chuang JY, Nakao M, Liu ST. 2010. MCAF1 and synergistic activation of the transcription of Epstein-Barr virus lytic genes by Rta and Zta. Nucleic Acids Res 38:4687-4700. http://dx.doi.org/10.1093/nar/gkq243.
55. Chang LK, Lee YH, Cheng TS, Hong YR, Lu PJ, Wang JJ, Wang WH, Kuo CW, Li SS, Liu ST. 2004. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1. J Biol Chem 279:38803-38812. http://dx.doi.org/10.1074/jbc.M405470200.
56. Chiu YF, Tung CP, Lee YH, Wang WH, Li C, Hung JY, Wang CY, Kawaguchi Y, Liu ST. 2007. A comprehensive library of mutations of Epstein-Barr virus. J Gen Virol 88:2463-2472. http://dx.doi.org/10.1099/vir.0.82881-0.
57. Hung CH, Chen LW, Wang WH, Chang PJ, Chiu YF, Hung CC, Lin YJ, Liou JY, Tsai WJ, Hung CL, Liu ST. 2014. Regulation of autophagic activation by Rta of Epstein-Barr virus via the extracellular signalregulated kinase pathway. J Virol 88:12133-12145. http://dx.doi.org/10.1128/JVI.02033-14.
58. Donaghy G, Jupp R. 1995. Characterization of the Epstein-Barr virus proteinase and comparison with the human cytomegalovirus proteinase. J Virol 69:1265-1270.
59. Conlan LA, McNees CJ, Heierhorst J. 2004. Proteasome-dependent dispersal of PML nuclear bodies in response to alkylating DNA damage. Oncogene 23:307-310. http://dx.doi.org/10.1038/sj.onc.1207119.
60. Plafker SM, Gibson W. 1998. Cytomegalovirus assembly protein precursor and proteinase precursor contain two nuclear localization signals that mediate their own nuclear translocation and that of the major capsid protein. J Virol 72:7722-7732.
61. Day PM, Roden RB, Lowy DR, Schiller JT. 1998. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J Virol 72:142-150.
62. Capuano CM, Grzesik P, Kreitler D, Pryce EN, Desai KV, Coombs G, McCaffery JM, Desai PJ. 2014. A hydrophobic domain within the small capsid protein of Kaposi's sarcoma-associated herpesvirus is required for assembly. J Gen Virol 95:1755-1769. http://dx.doi.org/10.1099/vir.0.064303-0.